By conjugating biomimetic cell membranes with dendritic cationic peptides, DNase I-loaded nanogels can be targeted to the joints of mice and subsequently alleviated RA symptoms in CIA mice via suppressing the TLR9 pathway (66). Here, TLR9 is linked to rheumatoid arthritis.